Industry snapshot
Key public data points
Historical & forecast
Base year 2023. Each series is official through its own latest government-data year (shown in the legend on each chart), and years beyond that are Claight estimates. As of July 2026 the current year is still in progress (2026 annual data is not yet published), so the forecast runs to 2028.
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Industry Definition and Scope
What does the Gynecologists & Obstetricians in European Union industry cover?
This industry encompasses medical specialist offices, private clinics, and specialized hospital units dedicated to female reproductive health, pregnancy care, childbirth, and postoperative recovery. The scope spans routine preventative screenings, high-risk obstetric monitoring, oncology diagnostics, and modern fertility or assisted reproductive therapy services.
- •Covers clinical fields including child and pediatric gynecology, reproductive medicine, and gynecological oncology.
- •Includes outpatient family planning centers that deliver medical interventions such as sterilization or pregnancy terminations.
- •Excludes general inpatient hospital services that do not maintain specialized, dedicated obstetric or gynecological units.
Market Structure and Operators
Who operates in the industry and how is it structured?
The European market is highly fragmented, consisting predominantly of independent private practices, public community health hubs, and localized corporate clinical networks. Public hospitals still manage a major share of acute obstetric events, while outpatient clinics dominate routine preventive screenings and elective treatments.
- •In major economies like Germany, over 13,422 specialists were registered as active in gynecology and obstetrics during recent reporting cycles.
- •A large portion of specialists are shifting into outpatient care structures, with Germany reporting a significant multi-decade surge in outpatient medical employment.
- •The sector features a highly gender-diversified workforce, where women represent approximately 64.6% of obstetrics and gynecology specialists in leading member states.
Demand Drivers
What drives demand in the industry?
Demand is heavily influenced by demographic changes, including declining birth rates and an increasing average maternal age. Furthermore, rising awareness of preventable women's cancers and the growing adoption of modern assisted reproduction technologies drive clinical volume.
- •The average age of women at the birth of their first child in the EU climbed to 29.9 years in 2024, compared to 28.8 in 2013.
- •Total live births in the EU declined to 3.55 million in 2024, illustrating the structural downward pressure on traditional labor and delivery services.
- •High mortality and incidence rates for gynecological malignancies, such as ovarian and endometrial cancers, maintain steady demand for specialized diagnostic and oncology care.
Competitive Landscape and Notable Public Companies
Who are the notable companies in the industry?
While frontline medical consulting and surgical delivery remain local, multinational medical technology, diagnostics, and pharmaceutical companies supply the critical clinical infrastructure. These operators provide key capital equipment, specialized therapies, and diagnostic instruments necessary to run modern clinics.
- •AstraZeneca PLC actively markets key therapeutic treatments for advanced gynecological oncology, including targeted ovarian and endometrial cancer therapies.
- •CooperCompanies Inc. (operating locally as CooperSurgical) is a key multinational player supplying medical devices, colposcopes, and fertility equipment to EU clinics.
- •Vitrolife AB is a prominent European biotechnology company specializing in assisted reproduction technologies and media used inside fertility clinics.
- •Karl Storz SE & Co. KG operates as a major developer and supplier of specialized gynecological endoscopes and hysteroscopic surgery equipment.
Recent Trends and Outlook
What are the recent trends and outlook?
Clinical practices are progressively shifting toward minimally invasive diagnostic techniques to reduce hospital stays and post-operative recovery times. Providers are also adapting to an aging workforce, which poses recruitment challenges in several Eastern and Southern European regions.
- •Hysteroscopic surgeries and uterine artery embolization are increasingly favored over traditional, highly invasive open hysterectomies.
- •A rapid aging trend in the medical workforce is evident, with several member states reporting that over 39% of practicing physicians are aged 55 or older.
- •Telemedicine and remote fetal monitoring technologies are gaining traction to support rural and underserved maternal care pathways.
Regulation and Compliance
How is the industry regulated?
Operators within the EU must navigate stringent regional and national health standards, licensing laws, and patient privacy frameworks. Professional certifications are regulated nationally but are influenced heavily by European-wide harmonized training standards.
- •Clinical medical practices comply with the European Union General Data Protection Regulation (GDPR) for all digital patient health records.
- •Medical devices used by gynecologists, such as ultrasound systems, must meet the rigorous standards of the EU Medical Device Regulation (MDR) (Regulation EU 2017/745).
- •National associations, such as the Hellenic Statistical Authority or the German Medical Association, enforce strict regional licensing requirements.
Sources
Government, statistical and trade sources used for this Claight analysis.
- Eurostat Population and Social Conditions Databases 2024 ·
- Hellenic Statistical Authority (ELSTAT) Health Professionals Survey 2023 ·
- World Health Organization (WHO) European Database on Human and Technical Resources for Health 2026 ·
- AstraZeneca PLC Annual Report and Sustainability Publications 2025
Claight analysis of public industry data.